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Abstract
ATR activation is dependent on temporal and spatial interactions with partner proteins. In the budding yeast model, three
proteins – Dpb11TopBP1, Ddc1Rad9 and Dna2 - all interact with and activate Mec1ATR. Each contains an ATR activation domain
(ADD) that interacts directly with the Mec1ATR:Ddc2ATRIP complex. Any of the Dpb11TopBP1, Ddc1Rad9 or Dna2 ADDs is
sufficient to activate Mec1ATR in vitro. All three can also independently activate Mec1ATR in vivo: the checkpoint is lost only
when all three AADs are absent. In metazoans, only TopBP1 has been identified as a direct ATR activator. Depletion-
replacement approaches suggest the TopBP1-AAD is both sufficient and necessary for ATR activation. The physiological
function of the TopBP1 AAD is, however, unknown. We created a knock-in point mutation (W1147R) that ablates mouse
TopBP1-AAD function. TopBP1-W1147R is early embryonic lethal. To analyse TopBP1-W1147R cellular function in vivo, we
silenced the wild type TopBP1 allele in heterozygous MEFs. AAD inactivation impaired cell proliferation, promoted
premature senescence and compromised Chk1 signalling following UV irradiation. We also show enforced TopBP1
dimerization promotes ATR-dependent Chk1 phosphorylation. Our data suggest that, unlike the yeast models, the TopBP1-
AAD is the major activator of ATR, sustaining cell proliferation and embryonic development.
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Introduction
In response to endogenous and exogenous stress, cells have
evolved a range DNA damage response (DDR) pathways to
maintain genomic stability [1,2,3,4]. In all eukaryotes, two
evolutionarily conserved PI3-kinase-like protein kinases, ATM
(Ataxia telangiectasia mutated) and ATR (ATM- and Rad3-
related) respond directly to DNA damage to control cell-cycle
progression and regulate other DNA damage responses such as
DNA repair and apoptosis. ATM activation is triggered by double-
strand breaks (DSBs), whereas ATR activation is induced by single
stranded DNA (ssDNA) occurring due to replication stress,
resected-DSBs or other single strand lesions [5,6,7,8].
In all eukaryotic organisms, ATR is found associated with
ATRIP (ATR-interacting protein) which is necessary to recruit
ATR to RPA-coated ssDNA [9,10,11,12]. In metazoans, but not
in yeasts, this correlates with ATR autophosphorylation at
T1989 [13,14]. Pre-requisite for ATR activation is the
independent recruitment of the Rad17-RFC checkpoint clamp
loader to the junction of RPA-coated ssDNA and double
stranded DNA (dsDNA), where it facilitates the loading of the
Rad9-Hus1-Rad1 (9-1-1) sliding clamp [15]. The co-recruit-
ment of ATR and the 9-1-1 clamp establishes a platform for
activation of the ATR pathway [13,16,17]. The C-terminus of
the Rad9 subunit of the 9-1-1 clamp is responsible for recruiting
TopBP1 [18,19,20], a conserved multi-BRCT-domain scaffold-
ing protein [21]. In yeast model systems, the Rad9 C-terminus
must be phosphorylated by ATR to provide a docking site for
phospho-protein binding domains within TopBP1 [18,20]. In
metazoans, Rad9 is constitutively phosphorylated by CK2 and
thus TopBP1 recruitment does not require ATR-dependent
Rad9 phosphorylation.
Metazoan TopBP1 contains nine BRCA1 C-terminal (BRCT)
domains while the yeast homologs contain only four BRCT
domains. The TopBP1 BRCT domains define phospho-binding
motifs [22,23] that allow TopBP1 to scaffold distinct proteins and
protein complexes in response to the phosphorylation status of its
clients. In all eukaryotes, TopBP1 plays an essential role in the
initiation of DNA replication [21]. In yeast models, this function
reacts to cell cycle-dependent phosphorylation of two client
proteins, Sld2 and Sld3, allowing TopBP1 to bridge an interaction
between two replication factors in order to promote Cdc45 and
GINS loading to activate the replicative helicase [24]. A similar
role is evident in metazoans, where TopBP1 association with the
Sld2 homolog, Treslin, is essential for replication initiation
[25,26,27].
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In response to ssDNA during DNA replication stress or DNA
repair, yeast TopBP1 performs an equivalent scaffolding role,
bridging between the 9-1-1 checkpoint clamp and the checkpoint
mediator proteins (the 53BP1 homologs) which present checkpoint
effector kinases (Chk’s) to ATR [28,29,30]. This scaffolding role is
essential for a functional ATR-Chk response. In addition, yeast
TopBP1 contains a conserved ATR activation domain (AAD)
which, when over-expressed, can directly induce ATR activation
in the absence of DNA damage [11,31,32]. The yeast TopBP1
AAD participates in, but is not necessary for, ATR activation:
AAD-deficient separation of function mutants display only
sensitivity to genotoxins and partial, cell cycle-specific checkpoint
defects [32,33]. As observed in the yeast models, metazoan
TopBP1 is similarly required for activation of the ATR-Chk1 axis
and is recruited to the site of DNA damage by binding to the C-
terminus of the 9-1-1 complex [16,31,34]. However, at this point,
significant differences emerge between the yeast and metazoan
systems: in addition to the constitutive formation of a 9-1-1
TopBP1 interaction in metazoans (see above), replacing Xenopus
TopBP1 with a recombinant protein containing a mutation in the
AAD (W1138) completely blocks ATR activation in response to
replication inhibition in extracts [31]. While extracts may not fully
recapitulate all aspects of the cellular environment, this suggests a
more important role for the metazoan TopBP1 AAD in ATR
activation when compared to yeast.
The differences between ATR activation in the yeast and the
metazoan systems are intriguing. In the yeast models, ATR
provides the bulk of the checkpoint signalling following all forms of
DNA damage, including DSBs. In metazoans, ATM provides the
majority of checkpoint signalling in response to DSBs, with ATR
playing a minor role. This distinction between yeasts and
metazoans can be explained, at least in part, by different repair
priorities: yeasts generally rapidly resect DSBs for repair by
homologous recombination, with non-homologous end joining
(NHEJ) - which occurs without significant resection - playing a
minor role. Conversely, metazoan cells rely largely on NHEJ and
thus detect DSBs through the ATM pathway. Experimentally
limiting resection in yeast models uncovers an ATM-dependent
checkpoint [35,36], demonstrating the underlying machinery is
conserved. The distinct repair priorities between yeast and
metazoan systems are likely to underpin changes in the
architecture of ATR activation mechanisms during evolution.
For example, it is notable that distinct pairs of BRCT-domains
mediate the 9-1-1 interaction in yeasts and metazoans: 9-1-1
interacts with BRCT 3+4, in yeasts (homologous to metazoan
BRCT 4+5) but with the conserved BRCT1+2 pair in metazoans
[21]. Furthermore, BRCT domains 7/8 in metazoans (which is
not conserved in yeasts) binds autophosphorylated ATR-T1989 to
promote a tight complex and strengthen ATR signalling [13,14].
Complete deletion of TopBP1 in untransformed mouse or
human primary cells induces cellular apoptosis and TopBP1
deficiency results in an early embryonic lethality [37,38,39,40,41].
Tissue specific deletion of TopBP1 in the central nervous system
(CNS) similarly leads to an accumulation of DNA breaks in
neuronal progenitors and subsequent disruption of neurogenesis
[42]. These data are consistent with the essential role for TopBP1
in the initiation of DNA replication. To specifically establish the
physiological function of the TopBP1 AAD, and to investigate if it
is dispensable for ATR activation in metazoans as it is in yeasts, we
generated a mouse model with a specific knock-in AAD mutation.
We show that the TopBP1 AAD is essential for the embryonic
development, phenocopies the lethal phenotype of ATR and is
necessary for ATR signalling after UV damage. These data
strongly suggest that, unlike in the yeast models, ATR activation of
by the TopBP1 AAD is the major, if not only, route to activating
the ATR-Chk1 axis and is essential for cell proliferation and
survival.
Results
To explore the function of the TopBP1 AAD, we generated a
specific knock-in allele of TopBP1 by gene targeting in mouse ES
cells. The AAD domain spans exons 19 and 20 (Fig. S1), with the
core indispensable aromatic residue, W1147 [31] encoded within
exon 20. To change W1147 to arginine (W1147R), T3439 was
mutated to C3439 in a targeting vector (Fig. 1A). A neomycin
resistance cassette (Neo) flanked by Frt sequences, was also
inserted into intron 19. Following electroporation into ES cells, 9/
200 neomycin-resistant clones contained the targeted allele
(Fig. 1B,C). A correctly targeted ES clone was used to derive
germline chimeric mice (designated as TopBP1tg/+). Crossing
TopBP1tg/+ mice with Flp transgenic mice (Jackson laboratory
strain 003946) led to generation of the desired TopBP1 AAD
knock-in allele, designated TopBP1ki/+ (Fig. 1A,D). The point
mutation was confirmed by sequencing mouse genomic TopBP1ki/+
DNA (Fig. 1E) and verified in cDNA from TopBP1ki/+ MEFs (Fig.
S2A). As expected, TopBP1 protein levels were similar between
TopBP1+/+ and TopBP1ki/+ MEFs (Fig. S2B). We also confirmed
that the AAD mutation did not compromise the protein expression
of TopBP1 when transfected into Cos7 cells (Fig. S2C).
Inactivation of TopBP1 AAD results in early embryonic
lethality
Heterozygous TopBP1ki/+ mice are viable and phenotypically
normal during a 2 year-observation period (data not shown).
However, no homozygous TopBP1ki/ki offspring were obtained
from TopBP1ki/+ intercrosses (167 live births genotyped, Table 1).
Backcrossing TopBP1ki/+ with TopBP1+/+ gave the expected ratio
of TopBP1ki/+ and TopBP1+/+ offspring, indicating that there were
no fertility defects in either the male or female TopBP1ki/+ animals
(Table 1). We thus analyzed deciduas and embryos derived from
TopBP1ki/+ intercrosses: genotyping at E11.5 revealed no homo-
zygous mutants (Table 1), although 17/48 deciduas were small,
precluding reliable PCR due to the presence of mother-derived
tissues (Fig. 2A). We next isolated blastocysts (E3.5) from
TopBP1ki/+ intercrosses for PCR genotyping: 21.7%, close to the
expected Mendelian ratio, of embryos were TopBP1ki/ki homozy-
gotes (Table 1). Although morphology was normal at isolation, all
TopBP1ki/ki blastocysts failed to outgrow in vitro cultures (Fig. 2B,
C). These data indicate that the TopBP1 AAD function is required
for embryo development beyond the blastocyst stage.
Author Summary
DNA damage checkpoint signalling is an essential com-
ponent of the DNA damage response. Many of the key
proteins initiating the checkpoint signal have been
identified and characterised in yeast. Here we explore
the role of the ATR activating domain (AAD) of TopBP1 in
embryonic development, cell growth and checkpoint
activation using a mouse model. In contrast to yeasts,
where the TopBP1 AAD plays a redundant, and thus
phenotypically minor, role in ATR activation, our data
demonstrate that the mouse TopBP1 AAD is essential for
cellular proliferation. Interestingly, this suggests evolution
has provided a simpler ATR activation mechanism in
metazoans than it has in yeasts.
Biological Role of TopBP1 as an ATR Activator
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TopBP1 AAD is required for cell survival and proliferation
The lethal phenotype of TopBP1-W1147R precluded the use of
TopBP1ki/ki MEFs for direct cellular assays. However, the presence
of the base change associated with the knock-in mutation
(T3439C) plus a second nucleotide polymorphism (Fig. S2A)
derived from the targeting construct (T3477C, a silent mutation)
offered the opportunity to specifically silence the TopBP1+ allele in
TopBP1ki/+ MEFs. We designed two independent shRNA expres-
sion vectors targeted against the wild type sequence, but predicted
to leave the knock-in allele resistant to RNA interference. Using
co-transfection with corresponding chimeric GFP-encoding re-
porters, these were tested individually in COS7 cells for their
ability to specifically target transcripts with the wild type (GFP-
wtAAD), but not the knock-in (GFP-mutAAD) TopBP1 sequences
(Fig. S3). The shRNA construct targeting the T3477C point
mutation, designated shTop2, efficiently targeted GFP-wtAAD but
not GFP-mutAAD. We thus transferred the shRNA construct into
a vector expressing GFP to create GFP-shTop2. The co-
expression of GFP from the shRNA vector will allow selection
for transfected cells.
GFP-shTop2, or a GFP-shLuciferase (GFP-shLuc) control, was
transfected into TopBP1ki/+ MEFs previously immortalized by a
3T3 protocol. GFP-positive cells were sorted by FACS 36 hours
after transfection (Fig. S3D). Semi-quantitative reverse transcrip-
tion PCR (RT-PCR) indicated that, in comparison to GFP-shLuc
control transfected cells, TopBP1 mRNA levels were reduced
upon GFP-shTop2 transfection. Sequencing revealed that the
remaining TopBP1 mRNA was predominantly the AAD mutant
form (Fig. 3A). Western blot analysis revealed a reduction of
,50% for the TopBP1 protein following GFP-shTop2 transfec-
tion of TopBP1ki/+ cells when compared to GFP-shLuc control
transfected cells (Fig. 3B,C). Corroboration of the specificity of
GFP-shTop2 to the wild type TopBP1 transcript comes from the
observation that GFP-shTop2 efficiently knocked down TopBP1
Figure 1. Generation of TopBP1 AAD mutant transgenic mice. (A) Schematic of the C-terminus of the TopBP1 locus: wild type (wt), targeted
(tg) and knock-in (ki) alleles. The red line marks the targeting vector. Exons are numbered in the boxes, Southern blot probes (p8 and p5), sizes of
DNA fragments after indicated enzyme digestion and the location of primers for PCR genotyping are shown. The targeting vector contained a
neomycin resistance gene (Neo) flanked by two frt sites (grey triangles). Exon 20 is flanked by two loxP sites (black triangle). Tryptophan 1147 (W1147)
was mutated into arginine in AAD by replacing T3439 with C in exon 20. (B–C) Southern blot analyses of gene targeted ES cell clones: Homologous
integration was verified by digestion with AseI and hybridization with a 59 external probe (p8) and by PpuMI digestion and hybridization with a 39
external probe (p5). (D) PCR genotyping analysis of the wild type, targeted and the knock-in allele following Neo excission. (E). Sequencing of
genomic DNA from TopBP1ki/+ heterozygous MEFs confirms the mutation of TTT (tryptophan) to TTC (Arginine) (W1147R).
doi:10.1371/journal.pgen.1003702.g001
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levels in TopBP1+/+ MEF cells (Fig. 3B,C). In the following
experiments, we designated GFP-shTop2-transfected TopBP1ki/+
cells as GFP-TopBP1ki/2 and GFP-shLuc transfected TopBP1ki/+
cells as GFP-TopBP1ki/+.
To identify the consequences of specific loss of TopBP1 AAD
function in cell survival and proliferation we followed the
proportion of the GFP positive cells after GFP-shTop2 or GFP-
shLuc transfection. 24 hours after transfection, the GFP+
population was similar for GFP-TopBP1ki/2 (GFP-shTop2
transfected) and control GFP-TopBP1ki/+ cells (GFP-shLuc
transfected). However, 5 days after transfection the proportion
of GFP-TopBP1ki/2 cells was significantly reduced when com-
pared to GFP-TopBP1ki/+ cells (Fig. 3D). Immunostaining against
cleaved Caspase 3 revealed a mild (but not statistically significant)
increase of apoptosis in GFP-TopBP1ki/2 when compared to
control GFP-TopBP1ki/+ cells 4 days after of transfection (Fig. 3E).
This suggests that delayed proliferation as opposed to apoptosis is
the major cause of the reduced number of GFP-TopBP1ki/2 cells.
To further characterise the effect of the AAD mutation on cell
proliferation, cells were pulse-labeled with EdU for 2 hours either
36 or 84 hours following transfection. Consistent with reduced
proliferation, the percentage of GFP+ cells that were also positive
for EdU in GFP-TopBP1ki/2 cultures was reduced when
compared to GFP-TopBP1ki/+ controls (Fig. 3F, G). Nonetheless,
a significant proportion of GFP-TopBP1ki/2 cells were also EdU+,
consistent with the AAD mutation being dispensable for DNA
replication.
Following transfection with GFP-shLuc, control (GFP-
TopBP1ki/+) cells became confluent after 5 days in culture.
However, the density of GFP-TopBP1ki/2 cells following transfec-
tion with GFP-shTop2 did not significantly increase over the same
period (Fig. 4A). GFP-TopBP1ki/2 cells became giant and flat after
4 days in culture (Fig. 4A) and this was often associated with b-
galactosidase positive staining, indicative of cellular senescence
(Fig. 4B,C). Consistent with this, RT-PCR analysis revealed up-
regulated expression of p19ARF and p21, known senescence
markers, in senescent GFP-TopBP1ki/2 cells (Fig. 4D). We
conclude that loss of TopBP1 AAD function results in proliferation
defects and promotes entry into senescence.
Activation of the ATR-Chk1 pathway in AAD-mutant cells
To test if the TopBP1 AAD mutation affected activation of the
ATR pathway following DNA damage treatment we analyzed
Chk1 phosphorylation following UV irradiation. First we estab-
lished that, in our assay, UV irradiation resulted in RPA foci
formation - an event occurring upstream from, and independent
of, ATR activation. As expected, UV treatment resulted in similar
patterns of RPA foci in GFP-TopBP1ki/2, GFP-TopBP1ki/+ and
non-transfected control cells. Inhibition of ATR activity using the
chemical inhibitor (ATRi; ETP-46464 [43]) similarly did not affect
RPA localization after UV (Fig. 5A). Conversely, Immunostaining
for phosphorylated Chk1 (p-Chk1-S317) to detect substrates
downstream of ATR activation showed a dramatic increase of
pChk1 in untransfected and GFP-TopBP1ki/+ (shLuc transfected)
cells, whereas GFP-TopBP1ki/2 (shTop2 transfected) and ATRi-
treated TopBP1ki/+ cells showed attenuated p-Chk1-S317 staining
to similar levels (Fig. 5B,C). Verifying the specificity of the assay,
UV-induced p-Chk1-S317 staining was fully abrogated in
TopBP1ki/+ cells following GFP-shChk1 transfection (Fig. 5B)
[44]. These data are consistent with an expectation that TopBP1
AAD function is necessary to activate ATR in response to UV
treatment.
Figure 2. Inactivation of the AAD results in early embryonic developmental defects. (A) Decidua at E11.5 from intercrossing of TopBP1ki/+mice.
Decidua in (I) was genotype ki/+. Decidua in (II) was empty, thus with unclear genotype. Bar= 1 mm. (B) Cultures of E3.5 blastocysts from TopBP1ki/+
intercrosses. D1: 1 day after culture, D4: 4 days after culture. Arrows indicate inner cell mass (ICM). Bar =50micrometers. Genotypes are indicated on the top
of respective images. (C) Example of PCR genotyping from ICM of blastocyst outgrowth. Expected product size for alleles labeled. ki= knock-in; wt=wild
type.
doi:10.1371/journal.pgen.1003702.g002
Table 1. Genotype distribution of offspring from TopBP1ki/+
breeding.
Mating Stage +/+ ki/+ ki/ki Unclear Total
TopBP1ki/+ (f)
x TopBP1ki/+ (m)
p0 22 22 - 5 49
TopBP1+/+ (f)
x TopBP1ki/+ (m)
P0 15 20 - 3 38
TopBP1ki/+ x
TopBP1ki/+
P0 59 108 0 - 167
TopBP1ki/+ x
TopBP1ki/+
E11.5 10 21 0 17* 48
TopBP1ki/+ x
TopBP1ki/+
E3.5 6 12 5 - 23
Genotyping analysis of offspring derived from AAD-mutant heterozygote
backcrosses (ki/+ x +/+) and intercrosses (ki/+ x ki/+). P0: postnatal day 0; +/+,
wild type; ki/+, heterozygotes mutant; ki/ki, homozygotes knock-in mutant; f,
female; m, male.
*: These embryos were too small to reliably define their genotype.
doi:10.1371/journal.pgen.1003702.t001
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ATR activation induced by dimerization of TopBP1 is AAD
dependent
It has previously been established that phosphorylation of
human TopBP1 within the AAD at S1159 (analogous to mouse
S1161) by Akt/PKB facilitates TopBP1 oligomerisation [45,46].
To establish if our AAD mutation compromises ATR activation
by preventing TopBP1 oligomerisation, we adopted an experi-
mental approach that exploits inducible dimerization: TopBP1
was fused to FKBP-F36V (Fig. 6A), a mutant form of FKBP12
that forms a dimer upon binding to the synthetic ligand AP20187
[47]. Flag- and HA-tagged wild type TopBP1 (wtTopBP1) or
TopBP1-W1147R (mutTopBP1), each fused with FKBP, were
co-expressed in all combinations. Cells were then treated with
AP20187 and extracts assayed for expression and co-precipitation
of HA-tagged protein by the Flag-tagged protein. As expected,
interactions mediated by AP2187 ligand were observed for all
combinations (Fig. 6B) consistent with the expectation that a
point mutation in the AAD does not disrupt FKBP-induced
dimer formation.
Interestingly, when we transfected HA-FKBP-wtTopBP1 into
cells we observed that the dimerization of TopBP1 induced by
AP20187 promoted ATR-dependent Chk1 phosphorylation
(ATRi treatment abolished phosphorylation; see lane 6). Unex-
pectedly, this was independent of DNA damage treatment (Fig. 6C:
compare lanes 2 with 4). We next exploited this dimerisation-
induced Chk1 phosphorylation to establish if the requirement for
the TopBP1 AAD in ATR activation could be bypassed by forced
dimerisation. HA-FKBP-wtTopBP1, HA-FKBP-mutTopBP1 and
the controls HA-FKBP and HA-wtTopBP1 were each transfected
into cells and AP20187 ligand-dependent Chk1 phosphorylation
monitored. Neither FKBP alone or TopBP1 alone resulted in
Chk1 phosphorylation in response to AP210187 ligand. As
expected, HA-FKBP-wtTopBP1 expression resulted in Chk1
phosphorylation upon ligand addition (Fig. 6D). Conversely,
HA-FKBP-mutTopBP1experssion did not induce Chk1 phos-
phorylation in response to ligand. Suggestive of a dominant
negative effect, Chk1 phosphorylation in these cells was impaired
below background upon AP20187-induced interaction (Fig. 6B,
Figure 3. AADmutation compromises cell proliferation and promotes cellular senescence. (A) RT-PCR and sequencing analysis of TopBP1
mRNA in sorted GFP-positive TopBP1ki/+ cells after transfection with indicated vectors. (B) Immunoblot analysis of protein extracts from GFP-positive
TopBP1ki/+ or TopBP1+/+ cells 36 hr after transfection with GFP-shLuciferase (GFP-shLuc) or GFP-shTop2. (C) Quantification of TopBP1 in B. Average of
two independent experiments. (D) Percentage of GFP+ cells in the TopBP1ki/+ cell population at day 1 (D1) and days 5 (D5) following shRNA
transfection. Results represent 3 independent experiments for each time point. Student’s t-test was used for statistical analysis. (E) Quantification of
cleaved caspase 3-positive cells by immunostaining 84 hr after shRNA transfection. The data represent the mean 6 SD of at least 1000 cells and two
independent experiments. P value: Student’s t-test. (F) Representative image of TopBP1ki/+ cells plus-labeled with EdU (red) 36 hr after transfection
with GFP-shLuc or GFP-shTop2 vectors. DNA was stained with DAPI (blue). Arrows point to EdU and GFP double positive cells (EdU+GFP+) cells. (G)
Quantification of the percentage of Edu+GFP+ in the total GFP+ population at 36 hr and 84 hr after shRNA transfection. The data represent the mean
6 SD of at least 1000 cells for each group and three independent experiments. P value: Student’s t-test.
doi:10.1371/journal.pgen.1003702.g003
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D). These results indicate that induced oligomerisation of TopBP1
is sufficient to induce ATR activation and subsequent Chk1
phosphorylation and that this requires the TopBP1 AAD function.
Discussion
In both metazoans and in the yeast models, TopBP1 is required
both for the initiation of DNA replication and for signalling
through the ATR pathway [21]. Using the yeast models, the main
function of TopBP1 in replication has been elucidated: TopBP1
acts as a scaffold, read the phosphorylation status of client proteins
to promote the formation of the replicative helicase [24,25,26,27].
A similar phosphorylation-dependent bridging function for
TopBP1 was identified during the transmission of the ATR
checkpoint [20]. An additional function for TopBP1, which was
first identified in metazoans [31] and later shown to be conserved
in the yeasts [11,32,33], is its ability to directly activate ATR
through an interaction between the TopBP1 AAD domain and the
ATR-ATRIP complex.
Depleting wild type TopBP1 from Xenopus and replacing this
with recombinant protein in which a single aromatic residue is
disrupted within the AAD abolished ATR activation in response to
replication inhibitors. This suggested a key role for the AAD in
activating the ATR checkpoint. However, in both the S. cerevisiae
and the S. pombe model organisms, while the AAD domain of the
TopBP1 homologs was similarly sufficient to activate ATR, either
in vitro or in vivo, it plays a relatively minor role in ATR
checkpoint signalling in response to DNA damage or replication
stress. Recent data from S. cerevisiae identified two further ATR
activating domains which play partially redundant roles in
checkpoint activation: one is contained within the C-terminus of
Ddc1Rad9, a 9-1-1 clamp subunit [48], while the other is found in
the Dna2 replication protein [49]. Interestingly, compromising the
function of all three AAD domains (Dpb11TopBP1, Ddc1Rad9 and
Dna2) in the same cells largely abolished activation of the ATR
pathway in S. cerevisiae. These data show that, in the yeasts,
multiple ATR activation domains promote ATR activation above
basal levels and that checkpoint function is dependent on ATR
activation by one or more AAD domains [50].
The TopBP1 AAD is required for embryo development
In the present study, we investigated the biological significance
of the TopBP1 AAD in a mouse model. We created a single point
mutation (W1147R) within the AAD of TopBP1 that removes a
key aromatic residue necessary for the activation of ATR. This is
predicted to separate the AAD function from other essential
functions such as the scaffolding role during replication initiation
and from any roles in scaffolding checkpoint complexes. Unex-
pectedly, this point mutation resulted in early embryonic lethality
and developmental arrest at the blastocyst stage. This early lethal
phenotype is equivalent to that reported for the complete knockout
of TopBP1 in mice [51] and is reminiscent of the consequence of
ATR deletion [52,53]. Due to the early lethality we could not
directly eliminate the possibility that the homozygous AAD knock-
in (TopBP1ki/ki) mutation had, in fact, generated a null mutation.
However, both the mRNA and TopBP1 protein levels were
produced at the expected levels by the AAD knock-in allele which
was visualized by specific shRNA knock-down of the wild type
TopBP1 mRNA in heterozygous MEFs (TopBP1ki/+) (see Fig. 3B
and Fig. S3B). Based on these data we propose that the TopBP1-
W1147R (AAD mutant) protein is stable and the phenotypes
observed are a direct consequence of the mutation introduced.
Our results thus suggest that one essential function for TopBP1 in
embryonic development is realized by a TopBP1 AAD-mediated
ATR activation function and that this cannot be substituted for by
other potential AAD domains. In addition, the scaffolding
functions of TopBP1 in replication initiation and checkpoint
activation cannot sustain embryonic development and are
insufficient for ATR activation.
The TopBP1 AAD plays a key role in cellular checkpoint
signalling
By establishing an shRNA knock-down assay which specifically
targeted the wild type, but not the TopBP1-W1147R (AAD
mutant) mRNA, we were able to examine the effect of the AAD
mutation in MEFs. Our first observation is that MEFs containing
only mutated TopBP1-W1147R (GFP-TopBP1ki/2) were not able
to proliferate and entered senescence. This is consistent with the
early embryonic lethality and strongly suggests an essential cellular
role for the TopBP1 AAD, presumably by activating ATR. Our
preferred explanation is that specific lesions are generated in
mammalian cells during DNA replication and that, in response to
these, only the TopBP1 AAD is capable of activating ATR. Such
an explanation does not preclude the existence of additional ATR
activating domains in other proteins (as is observed in the yeasts)
but would suggest that, if these exist, they respond to alternative
DNA structures or to structures formed at different points in the
cell cycle, for example only in G1.
Induced DNA damage, such as that caused by UV irradiation,
arrests cell proliferation via cell cycle checkpoint activation. We
examined the response of cells to UV irradiation and observed
that, in the absence of the wild type protein (via shRNA knock-
down), cells expressing the TopBP1-W1147R (AAD mutant)
protein were unable to mount a significant ATR response. The
parsimonious explanation for this is that, in mammalian cells, the
TopBP1 AAD is either the main or the sole mechanism for
activating ATR. Given the additional complexity evident in the
yeasts, this is surprising to us: evolution is prone to elaborate
Figure 4. AAD mutation induces premature cellular senes-
cence. (A) GFP+ TopBP1ki/+ cells were sorted 24 hr after transfection
and cultured. Images show the cell density and morphology at D1 and
D5. Enlargement shows a representative area of TopBP1ki/2 cells from
D5. (B) SA-b-galactosidase staining of cells 6 days after shRNA
transfection shown in blue. (C) Quantification of SA-b-galactosidase
positive cells from B. The data represent the mean 6 SD of at least 500
cells from 2 independent experiments. P value: Student’s t-test. (D)
Semi-quantitative RT-PCR analysis of RNA isolated from D5 cultures
from A. The expression level (indicated on top of each sample) was
estimated by quantification normalized to the level of GAPDH and then
correlated with GFP-shLuc transfected cells. Two independent exper-
iments were performed which showed equivalent results.
doi:10.1371/journal.pgen.1003702.g004
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mechanistic pathways as organisms become multicellular and
more complex. Nonetheless, our data suggest that the TopBP1
AAD is responsible for the majority of ATR signaling and that
additional ATR activating domains play little or no role in
metazoan checkpoint responses.
The inhibition of TopBP1 expression by antisense oligomers or
by siRNA induces apoptosis in cancer cell lines or MEF cells
[37,38,39,40,41]. In contrast, we did not observe a statistically
significant increase in apoptosis when cells grew in the presence of
the TopBP1 AAD defective protein (GFP-TopBP1ki/2). Instead,
we observed increased cellular senescence that was associated with
elevated expression of p19 and p21. Full loss of TopBP1 function
would be expected to disrupt replication initiation, whereas the
specific loss of the AAD function may allow replication but lead to
an accumulation of spontaneous damage that subsequently signals
through the ATM pathway. Consistent with this, we did observe
some incorporation of EdU in GFP-TopBP1ki/2 cells and we thus
suggest that the reduced proliferation and increased cellular
senescence observed in GFP-TopBP1ki/2 cells stems from impaired
G1/S transition likely resulting from ATM activation. MEF cells
deleted for ATR similarly show an increase in cellular senescence,
a reduction of proliferation and only a small increasing of in
apoptosis [54]. This is also consistent with our expectation that the
TopBP1 AAD mutation specifically affects the ATR-Chk1 cascade
without preventing replication initiation.
Forced TopBP1 oligomerisation results in ATR activation
While establishing that the AAD mutation in TopBP1 was not
preventing ATR activation due to a dimerization defect, we found
that forced dimerization of TopBP1 strongly stimulated ATR
activation in the absence of induced DNA damage, as judged by a
significant increase in Chk1phosphorylation. While oligomerisa-
tion can lead to increased protein stability and improvements to
enzymatic activity [55], we did no observe any increase of the
TopBP1 protein level following induced oligomerisation. Several
alternative possibilities could account for ATR activation by
oligomerised TopBP1: oligomerisation may enhance the affinity of
TopBP1 for its interaction partners. In this regard, it is interesting
to note that phosphorylation of Ser1131 (ortholog of human
Figure 5. Mutation of AAD impairs ATR-Chk1 pathway in vivo. (A) Immunostaining of RPA (red and upper panel) in TopBP1ki/+ cells 36 hr after
transfection with GFP-shLuc or GFP-shTop2 without or with the indicated treatment. ATRi, ATR inhibitor. GFP-shLuc or GFP-shTop2 transfection is
visualized by GFP (green). DNA was stained with DAPI (blue). Inset shows the enlargement of selected areas. (B) Immunostaining of phosphorylation
of Chk1-S317 (pChk1, red, upper panel) in TopBP1ki/+ cells 36 hr after transfection with GFP-shLuc or GFP-shTop2 without or with the indicated
treatment. ATRi, ATR inhibitor. GFP-shLuc or GFP-shTop2 transfection is visualized by GFP (green). DNA was stained with DAPI (blue). GFP-shChk1
transfection (right panel, arrows) served as a negative control for pChk1 staining. (C) Quantification of fluorescent density of phosphor Chk1-S317
staining (pChk1) of indicated samples from B. The data represent the mean 6 SD of at least 200 cells (or GFP positive cells) and were repeated three
times. One-way ANOVA pair-test was performed for the statistical analysis. ***P,0.001; n.s., not significant.
doi:10.1371/journal.pgen.1003702.g005
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TopBP1 Ser1140) in the AAD of Xenopus TopBP1 enhances
binding of to the Xenopus ATR-ATRIP complex, and thereby
increases the capacity of TopBP1 to activate the ATR [56].
Alternatively, oligomerisation of TopBP1 may enhances its
chromatin binding ability. In this regard it is interesting to note
that tethering TopBP1 [57] or the S. pombe homolog (Rad4TopBP1) to
chromatin [32] activates the ATR and Chk1-dependent checkpoint.
As expected, despite the forced oligomerisation of the AAD mutant
of TopBP1, it failed to stimulates ATR activity, strongly suggesting
that TopBP1 oligomerisation is necessary but not sufficient for ATR
activation and that an intact AAD is required.
Materials and Methods
Vector construction for gene targeting, over-expression
and shRNA knockdown
Gene targeting vector was constructed with Red/ET recombi-
neering technology (Gene Bridges). Briefly, a LoxP-Neo-LoxP
cassette was inserted into bacmid (bMQ-304N19, Geneservice)
encompassing the genomic region of TopBP1, using the Red/ET
Quick and Easy BAC Modification Kit. The Neo cassette was
subsequently excised by expression Cre recombinase in host
bacterial cells, resulting in a one LoxP site in intron 20. Next, a
second Flp-Neo-Flp cassette was inserted into intron 19. Mutation
of Tryptophan to Arginine at 1147 was achieved by in vivo
substitution of T3439 by C3439 (Counter-Selection BAC Mod-
ification Kit, Gene Bridges). The engineered genomic region of
TopBP1 in bacmid was then subcloned into high-copy plasmid
vector (ColE1) by homologous recombination, resulted in the
targeting construct of TopBP1-W1147R.
Flag-tagged full length wild type or W1147R mutant TopBP1
were amplified by PCR with 59-primer TopFL-5 (TACGGA-
TCCCTCGGGCTCCACCTAGTTCA) and 39- primer TopFL-
3 (CCGCTCGAGGCCGTTTGACTACATTC) and constructed
into pCMV-tag 2C (Stratagene), pcDNAHA, or pcDNA-
HA2FKBP vector, respectively [47]. GFP-tagged wild type or
W1147R mutant AAD of TopBP1 were amplified by PCR with
59-primer micTop54-2 (GAAGATCTTGACCCAGGCCTTG-
GAGATGAGAG) and 39-primer micTop34-2 (ACGCGTC-
GACTGCCCTGGGGCTTGAGTAACACA) and constructed
into pEGFP C2 (Clontech, Mountain View, CA, USA). The
construction of shRNA expression vectors was performed as
previously described [58]. Briefly, oligonucleotides targeting the
coding sequences and their complementary sequences were
inserted into the vector under the control of the human U6
promoter with or without CMV-driven EGFP. All the oligonu-
cleotides contained the following hairpin loop sequence: TTCAA-
GAGA. The targeting sequences used were: Luciferase: GGCTT-
GCCAGCAACTTACA, shTop1: TGAGCAGATCATTTGG-
GACG, and shTop2: TGGCTTGCCAGCAACTTACA. All the
constructions were confirmed by sequencing. shRNA expression
vector to target Chk1 was reported as previously [44].
Gene targeting of TopBP1 AAD mutant allele,
genotyping of ES cells and mice by Southern blot, PCR
and sequencing
The gene targeting vector was linearized by Cla I digestion and
electroporated into the E14.1 ES cells. After selection with G418,
correctly targeted TopBP1W1147R knock-in (ki) ES clones were
identified by Southern blot analysis and used to generate germline
Figure 6. Inducible dimerization of TopBP1 activates ATR-Chk1.
(A) Schematic showing the inducible dimerization. Addition of AP20187
induces dimerization (interaction) of FKBP-containing proteins. (B)
Immunoprecipitation (IP) coupled immunoblot (IB) analysis of HEK293T
cells that were transfected with the indicated vectors (Flag-tagged and
HA-tagged). Cells were treated with 100 nm of AP20187 for 1 hr and
analyzed by IP-IB using indicated antibodies. (C) IP-IB analysis of HEK293T
cells after transfection with empty vector (HA-FKBP) or wild type TopBP1
(HA-FKBP-wtTopBP1). Cells at 40 hr after transfection were incubated
with 100 nm of AP20187 for 1 hr without or with 1.6 mM of ATR inhibitor
(ATRi) or were treated with 100 J/m-2 UV. Immunoblot analysis was
performed 1 hr after respective treatment. (D) IP-IB analysis of HEK293T
cells after transfection with empty vector (HA-FKBP), or FKBP-fused wild
type TopBP1 (HA-FKBP-wtTopBP1), or FKBP-fused AAD mutant TopBP1
(HA-FKBP-mtTopBP1), or wild type TopBP1 without FKBP (HA-wtTopBP1).
Cells were treated with 100 nm of AP20187 for 1 hour then analysed by
immunoblotting with indicated antibodies.
doi:10.1371/journal.pgen.1003702.g006
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chimeric mice. To analyze the 59-arm integration of the targeting
vector into the TopBP1 locus, ES cell DNA was digested with AseI
and probed with an intron-16 probe (p8) located externally to the
upstream of targeting area. 39-arm integration of the targeting
vector was analyzed by digestion the DNA with PpuM 1 and
hybridization with an intron-27 probe (p5) located externally to
the downstream of targeting area (see Fig. 1A).




TA; neo-1f: ATCTCCTGTCATCTCACCTTGC. The primer
pair Top158 and Top159 was used to detect the wild type allele
(wt) and targeted allele (tg) or knock-in targeted allele (ki).
Combination of In19-1f, neo-1f and In19-2r detects the remove
of neo-cassette in targeted allele. For sequencing genotyping of the
TopBP1W1147R ki allele, genomic DNAs were isolation and
sequenced with primer In19-1f.
mRNA isolation and semi-quantitative PCR
The total RNA was isolated by using Tri Reagent (T9424,
Sigma-Aldrich, Munich, Germany). 1 mg of RNA was used for
synthesis of first-strand cDNA by Affinity Script Multiple Temper-
ature cDNA Synthesis Kit (200436, Stratagene) according to the
manual. Semi-quantitative PCR was performed with the following
primers. For TopBP1: micTop54-2 and micTop34-2 (see 4.1); for
GAPDH: forward primer mGAPDH15 (GCACAGTCAAGGCC-
GAGAAT) and reverse primer mGAPDH13(GCCTTCTCCA-
TGGTGGTGAA); For p19ARF: forward primer p19f (CCCAC-
TCCAAGAGAGGGTTT) and reverse primer p19r (TCTGCAC-
CGTAGTTGAGCAG); For p21: forward primer p21f(GTCAGG-
CTGGTCTGCCTCCG) and reverse primer p21r (CGGTCC-
CGTGGACAGTGAGCAG).
Primary MEF isolation and cell culture, transfection,
sorting and stability analysis
Primary mouse embryonic fibroblasts (MEFs) were isolated from
E13.5 embryos derived from the mating between TopBP1ki/+ mice
and immortalized with a standard 3T3 protocol [59]. For
transfection, 3T3MEFs were transfected using Amaxa Nucleofector
Kit R (VCA-1001, LONZA, Cologne, Germany). Briefly, MEFs
were trypsinized and 16106 cells were centrifuged at 2006 g for
10 min. The cell pellet was resuspended in 100 ml Nucleofector
Solution mixture plus 5 g of plasmid-DNA. The cell suspension was
electroporated using Nucleofector I Device (Lonza). The electro-
porated MEFs were cultured under normal conditions for 24 hr
before FACsorting based on GFP expression. The sorted cells were
either used for protein extraction, mRNA isolation or further
cultured in the presence of 400 ug/ml of G418 (Invitrogen). For
EdU labeling, cells were incubated with 1 mg/ml of EdU (A10044,
Invitrogen) for 2 hr at 36 or 84 hr after transfection. UV exposure
and HU treatment were performed at 36 hr after transfection and
cells were fixed with 4% PFA for immunofluorescence staining. For
ATR inhibitor treatment, 1.6 mm ATR inhibitor (ATRi) was added
1 hr before exposure to 100 J/m2 of UV. Cos7 or HEK293T cells
were transfected with lipofectamine2000 (11668-019, Invitrogen)
according the manufacturer’s instruction
Immunostaining, EdU reaction and b-galactosidase
staining
Immunostaining was performed on as described previously [44].
Briefly, PFA-fixed cells were incubated with blocking buffer (1%
BSA, 5% goat serum and 0.4% Triton X-100 in PBS) for 1 hr at
room temperature then with a primary antibody diluted in
blocking buffer at 4uC overnight followed by secondary antibodies
for 2 hr at room temperature. After washing, the slides were
mounted with DAPI-containing mounting medium (Invitrogen).
The primary antibodies and respective dilutions are: rabbit anti-
pChk1-S317 antibody (1:100, A300-163A-3, Bethyl Laboratories,
Montgomery, TX, USA); rabbit anti-Cleaved Caspase-3 (Asp175)
(1:300, 9662, Cell Signaling Technology, Danvers MA, USA) and
rat anti-RPA antibody (1:300, 2208, Cell Signaling Technology).
EdU detection was carried out using a Click-iT EdU Alexa Fluor
647 Imaging Kit (953624, Invitrogen) after fixation according to
the manufacturer’s instruction. b-galactosidase staining was
performed with a Senescence b-galactosidase staining kit (9860,
Cell Signaling Technology) according to the manufacturer’s
instruction. Cells images were acquired using a virtual microscope
(BX61VS, Olympus, Tokyo, Japan) or a confocal microscope
(LSM510, Zeiss, Jena, Germany). The density of fluorescent signal
was quantified by a high-content analysis microscopy (Cellomics
Arrayscan VTI, Pittsburgh, PA, USA).
Western blotting analysis
The proteins were extracted with RIPA buffer (20 mM HEPES,
pH 7.6, 20% glycerol, 0.5M NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, pH 8.0, 0.5% NP-40, 1 mM DTT, 1 mM PMSF, 5 mg/
ml leupeptin, 2 mg/ml aprotinin, 1 mM b-glycerophosphate,
1 mM Na3VO4 and 10 mM NaF) from cells. After separation in
SDS-PAGE, the membranes were blotted with the flowing
antibodies. The primary antibodies used in this study were rabbit
anti-TopBP1 antibody (1:1000, AB3245, Millipore, Schwalbach,
Germany), rabbit anti-phospho-S317-Chk1 (1:1000, A300-163A,
Bethyl Laboratories), Rabbit anti-HA (1:10000,A190-208A,
Bethyl Laboratories); mouse anti-b-Action (1:20000, C2206,
Sigma-Aldrich), mouse anti-Flag (1:10000, F4042, Sigma-Aldrich),
mouse anti- cH2AX (1:1000, 05-636, Millipore); sheep anti-Chk1
antibody (1:1000, ab16130, Abcam, Cambridge, UK).
Chemically induced dimerization of TopBP1
The inducible dimerization assay was performed as previous
described [47]. Briefly, HEK 293T cells were transiently
transfected with pcDNAHA2-TopBP1 or pcDNAHA2FKBP-
TopBP1 (or its AAD mutant counterpart). Forty hours later,
transfectants were either mock-treated with 0.1% ethanol or
treated with a 100 nM of the bivalent ligand AP20187 (635060,
Clontech) and/or combined with 1.6 mm ATR inhibitor (ATRi) for
1 hr. Immunoprecipitation was carried out as previous described
[47].
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Supporting Information
Figure S1 Structure alignment of TopBP1 AAD. Alignment of
the AAD sequences from different species. The protein sequence
of the AAD domain is highlighted by the solid line (under the
sequence) and the sequence encoded by exon 19 and exon 20 is
indicated by dashed lines (on top of the sequence). The frame
marks the mouse S1147 (equivalent to W1138 in Xenopus), where
a point mutation is introduced in the AAD mutant mouse model.
Solid arrow points to mouse S1140 (equivalent to S1131 in
humans) that is an ATM phosphorylation site. Empty arrow
indicates mouse S1161 (equivalent to S1159 in humans) that can
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be phosphorylated by AKT. H. sapiens: NP_008958; M. musculus:
NP_795953; X. laevis: NP_001082568; P. troglodytes: XP_516761;
R. norcegicus: XP_236578; G. gallus: XP_418794; C. failiaris:
XP_534266.
(PDF)
Figure S2 Expression analysis of AAD wild type and mutant
TopBP1. (A) Sequencing results from RT-PCR products derived
from +/+ and ki/+ MEFs demonstrate the introduced knock-in
mutation (T3439C, W1147R), and a silent mutation (T3477C,
L1159L) from the targeted allele. (B) Immunoblot analysis of
expression of endogenous TopBP1 in TopBP1+/+ and TopBP1ki/+
MEF cells. Two samples of indicated genotype are shown. (C)
Immunoblot analysis of expression of Flag-tagged wild type and
AAD mutant TopBP1 in Cos7 cells. Two samples of each
transfection are shown.
(PDF)
Figure S3 Establishment of AAD mutant cellular system. We
took advantage of the existence of the knock-in T3439C
(W1147R) mutation and of a silent mutation (T3477C) that was
discovered in the sequence of the targeted allele to establish an
allele-specific knock-down strategy. (A) Schematic of the vector-
base shRNA knock-down strategy. shTop1 and shTop2 oligos are
designed to specifically target wild type TopBP1 allele, but avoid
the introduced mutation (T3439C, W1147R) and silent mutation
(T3477C, L1159L), respectively. (B) A schematic diagram of
screening of shRNA oligos. shRNA were transfected together with
GFP-tagged wild type or mutant AAD fragment of TopBP1,
respectively. GFP positive staining (green) indicates no knock-
down by shRNA, whereas GFP negative cells indicate knock-down
by specific shRNA. (C) Images of cells co-transfected shRNA and
respective GFP-tagged AAD expression vectors. Control shRNA
expression vector (shLuciferase, shLuc), shTop1 or shTop2 were
co-transfected with GFP only, GFP-tagged wild type (GFP-
wtTopBP1) or AAD mutant fragment of TopBP1 (GFP-
mutTopBP1), respectively. Images were acquired 24 hr after
transfection. (D) FACS sorting of GFP+ cells at 36 hr after
transfection or knock-down as indicated. shTop2 specifically
silenced the expression of GFP-wtAAD but not GFP-mutAAD.
(PDF)
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